LATEST NEWS
More
Externally validated HPV-based prognostic nomogram for oropharyngeal carcinoma patients yields more...
Due to the established role of the human papillomavirus (HPV), the optimal treatment for oropharyngeal carcinoma is currently under debate. We evaluated the most important determinants of treatment outcome to develop a multifactorial predictive model that could provide individualized predictions of treatment outcome in oropharyngeal carcinoma patients.
FDA approves targeted therapy for first-line treatment of patients with a...
The U.S. Food and Drug Administration today approved Iressa (gefitinib) for the first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) whose...
SPECIALITTY AREAS
- All
- ASCO 2016
- Ash 2014
- brain tumor
- Breast cancer
- Cancer
- Chemotherapy
- CLL
- Conferences
- ECCO 2017
- Embedded Technology
- EONS 10
- ESMO
- Featured
- Imaging Technology
- Leukaemia
- Lung cancer
- Media
- Medical Devices
- Melanoma
- Metastatic
- Neutropenia
- Oncology
- Oncology Nursing
- Oropharyngeal cancer
- Ovarian cancer
- Pharmacy
- Prevention
- Prostate cancer
- Public Health
- Radio therapy
- Rare Tumors
- Rectal Cancer
- Research
- Sarcoma
- Specialities
- T cell
- Thyroid cancer
- vaccine
- Videos
- Viruses & Bacteria
- Wireless Technology
More
LATEST ARTICLES
- Advertisement -
